VZ Insider Filing: Kyle Malady Credited with 137.429 Phantom Stock Units
Rhea-AI Filing Summary
Kyle Malady, EVP and Group CEO - VZ Business at Verizon Communications Inc., reported a non-derivative change and a derivative acquisition under the company deferred compensation plan. On 09/11/2025 he was credited with 137.429 units of phantom stock (unitized), each representing an economic portion of a share and payable in cash under the deferred compensation plan. The filing shows 39 underlying common shares associated with the transaction and reports 388,718.361 shares of beneficial ownership following the transaction, held indirectly through the deferred compensation plan. The form was signed by an attorney-in-fact on 09/12/2025.
Positive
- 137.429 phantom stock units were credited to the reporting person, as disclosed in the filing
- The filing clarifies phantom stock units are cash-settled and include dividend reinvestment
- 388,718.361 shares are reported as beneficially owned indirectly following the transaction
Negative
- None.
Insights
TL;DR: Executive received 137.429 phantom stock units settled in cash, increasing indirect beneficial ownership to 388,718.361 shares.
The Form 4 discloses a routine deferred compensation credit rather than an open-market purchase or sale. The 137.429 phantom stock units are described as economic equivalents payable in cash and include dividend reinvestment. The filing reports 39 underlying common shares tied to the phantom units and a total indirect beneficial ownership of 388,718.361 shares following the transaction. No purchase price or cash settlement date is provided; the entry is coded as an acquisition under the issuer's deferred compensation arrangements.
TL;DR: Disclosure reflects compensation-related credit to an executive via the company’s deferred compensation plan, reported under Section 16 rules.
The document identifies Kyle Malady as an officer and reports the grant/accrual of phantom stock units, with an explanation that units are cash-settled and payable per the plan. The filing notes inclusion of dividend reinvestment in the aggregate beneficial ownership figure. Signature by an attorney-in-fact is shown, and no amendments or corrective statements are indicated. The disclosure meets Section 16 reporting format for derivative and non-derivative columns as presented.
FAQ
What transaction did Kyle Malady report on Form 4 for VZ?
How are the phantom stock units settled according to the filing?
How many shares does the reporting person beneficially own after the reported transaction?
Does the Form 4 show a cash price or settlement date for the phantom units?
Who signed the Form 4 and when?